Fingerprint
Dive into the research topics where Kerry Rogers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Targeted Therapies for Lymphoid Malignancies
Woyach, J. A. (PI), Byrd, J. C. (CoPI), Johnson, A. J. (CoPI) & Rogers, K. (CoPI)
04/1/13 → 01/31/26
Project: Research
-
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Alsouqi, A., Huang, Y., Christian, B., Reneau, J., Bhat, S. A., Brammer, J., Sawalha, Y., Baiocchi, R. A., Grever, M., Rogers, K. A., Reeser, J., Smith, A., Samorodnitsky, E., Roychowdhury, S., Maddocks, K., Woyach, J. A. & Bond, D., Mar 2026, In: European Journal of Haematology. 116, 3, p. 326-329 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Gordon, B. K., Muhowski, E. M., Singh, J., Ravikrishnan, J., Peris-Cuesta, A., Diaz Rohena, D., Sanchez, J. R., Thangavadivel, S., Benrashid, S., He, A., Marr, A. R., Mitchell, A. D., Urrutia, J. M., Misra, S., Lai, T. H., Yu, L., Walker, B. R., Perry, E., Shukla, S. A. & Grieselhuber, N. R. & 12 others, , Jan 12 2026, In: Blood cancer discovery. 7, 1, p. 85-103 19 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases
Rogers, K. A., Muluneh, B., Qureshi, Z. P., He, J., Bokun, A., Ding, Z., Lafeuille, M. H., Gogna, P., Emond, B. & Fradley, M., Jun 2025, In: Journal of Comparative Effectiveness Research. 14, 6, e240210.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
Rogers, K. A., Yan, P., Flinn, I. W., Stephens, D. M., Kipps, T. J., Larson, S. M., Martz, L., Chen, X., Wang, H., Hopping, E., Bundschuh, R., Turkoglu, A., Lozanski, G., McGarry, C., Acosta, A., Sechaud, R., Baldoni, D., Chaudhury, A., Whalen, J. & Hassounah, N. B. & 4 others, , Dec 15 2025, In: Clinical Cancer Research. 31, 24, p. 5145-5158 14 p.Research output: Contribution to journal › Article › peer-review
-
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
Roncaglia, E., Gaffo, E., Calabretto, G., Fürstenau, M., Rogers, K. A., Baliakas, P., Cui, C., Miller, C., Haferlach, C., Plevova, K., Oscier, D., Davis, Z., Nguyen-Khac, F., Rigolin, G. M., Athanasiadou, A., Baran-Marszak, F., Valiente, A., Terol, M. J., Abrisqueta, P. & Espinet, B. & 32 others, , Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 74.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations